Simplex Trading
LVTX

Simplex Trading’s LAVA Therapeutics LVTX Stock Holding History

Simplex Trading’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-51
Closed – – 9156
2024
Q3 		$0 Sell
51
-175
-77% -$320 ﹤0.01% 9104
2024
Q2 		$0 Sell
226
-2,363
-91% -$6.24K ﹤0.01% 9380
2024
Q1 		$8K Buy
2,589
+2,149
+488% +$4.73K ﹤0.01% 7751
2023
Q4 		$0 Sell
440
-234
-35% -$334 ﹤0.01% 9394
2023
Q3 		$0 Sell
674
-468
-41% -$837 ﹤0.01% 9325
2023
Q2 		$2K Buy
+1,142
New +$2.11K ﹤0.01% 8444

Simplex Trading's LVTX Position: Q4 2024 in Review

Simplex Trading sold out of LAVA Therapeutics (LVTX) in Q4 2024, closing a stake of 51 shares.

Simplex Trading first reported a position in LVTX in Q2 2023 and held it in 6 quarters. The position peaked at $8K in Q1 2024. 22 funds tracked by Wall St. Rank hold LVTX as of Q4 2024.

  • Simplex Trading reported no remaining LAVA Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 51 LAVA Therapeutics shares in Q4 2024.
  • Simplex Trading first reported a position in LAVA Therapeutics in Q2 2023 and held it in 6 quarters.
  • Simplex Trading's LAVA Therapeutics position peaked at $8K in Q1 2024.
  • 22 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.